Management of Viral Upper Respiratory Infections

Clinical Context and Diagnosis

Viral symptoms typically include nasal congestion, clear rhinorrhea, cough, sneezing, and sore throat that peak within 3 days and resolve within 10-14 days, according to the American Academy of Otolaryngology-Head and Neck Surgery 1

Oral antihistamines like pheniramine can be used for symptomatic relief of excessive secretions and sneezing in viral rhinosinusitis, although the evidence base is limited, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
Antihistamines are listed among palliative medications that may be used alone or in varying combinations for symptom relief in VRS, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
For acute bacterial rhinosinusitis, antihistamines are discouraged in non-atopic patients due to questionable or unproven efficacy, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 2

Standard adult dosing for first-generation antihistamines like pheniramine is typically 25-50 mg three to four times daily, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 3
TID dosing provides consistent symptom coverage throughout the day for nasal congestion and rhinorrhea, according to the American Academy of Otolaryngology-Head and Neck Surgery 1

The combination of antihistamine with ibuprofen is rational and safe, with no significant drug interactions between pheniramine and ibuprofen, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

Add pheniramine (Avil) at standard dosing three times daily for nasal congestion and excessive secretions, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
Consider oral decongestants (e.g., pseudoephedrine) for additional nasal congestion relief, barring contraindications like hypertension or anxiety, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
Nasal saline irrigation provides minor symptom improvement with low risk of adverse reactions, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

First-generation antihistamines like pheniramine cause sedation, dry mouth, and urinary retention, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 3
Use caution in elderly patients due to anticholinergic effects, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 3
Topical decongestants should be limited to 3-5 days to avoid rebound congestion and rhinitis medicamentosa, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

The American College of Physicians recommends identifying viral respiratory illnesses based on clinical presentation, including symptoms such as body aches, chills, nasal congestion, and clear rhinorrhea, which are classic viral symptoms 4, 5
Physical examination findings, such as oropharynx redness without exudate, bilateral inferior turbinate swelling with clear rhinorrhea, and unilateral maxillary sinus tenderness, support a viral rather than bacterial etiology 6, 7
The American Academy of Family Physicians notes that symptoms lasting only 2 days do not meet criteria for bacterial rhinosinusitis, which requires either persistent symptoms >10 days, severe symptoms with high fever (>39°C) and purulent discharge for ≥3 consecutive days, or worsening after initial improvement ("double sickening") 4, 8

The American College of Cardiology and other guideline societies recommend avoiding antibiotics for viral respiratory infections, as they provide no benefit and increase adverse effects, with a number needed to harm of 8 4, 9
The Infectious Diseases Society of America recommends symptomatic treatment with over-the-counter analgesics, decongestants, cough suppressants, and warm saline gargles for viral upper respiratory infections 4, 5, 7
Patient education about the expected course of viral illness, hand hygiene, and respiratory etiquette is recommended by the Centers for Disease Control and Prevention 4, 5

The American Academy of Pediatrics recommends return precautions, including fever >100.4°F, respiratory distress, neck stiffness, or symptom worsening, for patients with viral upper respiratory infections 6, 5
Proper safety netting with specific return precautions is essential for ensuring patient safety and preventing unnecessary complications 6, 5

The Centers for Disease Control and Prevention recommends avoiding unnecessary antibiotic prescriptions for viral respiratory infections, as this contributes to antimicrobial resistance and increases adverse effects 4, 9
Appropriate antibiotic stewardship is critical for preventing the overuse and misuse of antibiotics, with the goal of reducing antimicrobial resistance and promoting high-value care 4, 9